Skip to main content
SpringerLink
Log in

Rifampicin reduces severe hepatotoxicity and costs versus isoniazid

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ronald LA, et al. Treatment with Isoniazid or Rifampin for Latent Tuberculosis Infection: Population-Based Study of Hepatotoxicity, Completion, and Costs. European Respiratory Journal : 24 Jan 2020. Available from: URL: http://doi.org/10.1183/13993003.02048-2019

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rifampicin reduces severe hepatotoxicity and costs versus isoniazid. Reactions Weekly 1790, 10 (2020). https://doi.org/10.1007/s40278-020-74629-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-74629-z

Search

Navigation